Advertisement

Inform Genomics, Inc. Company Profile

09:05 EDT 20th May 2013 | BioPortfolio

Inform Genomics, Inc. is a private company focused on developing a novel platform of personalized medicine products for cancer supportive care and inflammatory diseases. Our business model leverages existing technology in conjunction with proprietary analytic methods for conducting genome-wide association studies. Product development programs will lead to commercial, single source laboratory tests consisting of SNP clusters that determine the likelihood of individual patient clinical outcomes to drug therapies. The U.S. market opportunity for these differentiated products exceeds $2 billion annually. Inform Genomics is headquartered in Boston, Massachusetts.


News Articles [ 572 Associated News Articles listed on BioPortfolio]

SNPing side effects: Sidebar: Inform Genomics Inc. Corporate Profile

SNPing side effects Inform Genomics Inc. Boston, Mass. Technology: SNP-based test to predict chemotherapy side effects Disease focus: Diagnostic Clinical status: NA Founded: 2010 by Ed Rubenstein, Sus...

Inform Genomics Inc.

While other personalized medicine companies tend to focus on selecting the most effective therapeutic drug, say for cancer, Inform Genomics Inc.’s focus with its lead product is to identify patients...

Inform Genomics: SNPing side effects

Inform Genomics is developing a SNP-based test that aims to personalize the ability of physicians and patients to avoid the side effects of chemotherapy.

Inform Genomics Announces Positive Top-Line Results in First Phase of Development for OnPART(TM) Personalized Medicine Product

Boston, MA, Oct. 1, 2012 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a private company focused on developing novel platforms of genomic-based personalized medicine products for cancer supportive care...

Inform Genomics Presents Results For OnPART(tm) Showing High Degree Of Accuracy Predicting Six Common Side Effects Of Dose Dense Chemotherapy

Boston, MA, Dec. 6, 2012 (GLOBE NEWSWIRE) --  Inform Genomics, Inc., a private company focused on developing novel platforms of genomic-based personalized medicine products for cancer supportive car...

Genomics center gets $1.8M to study livestock

The Roslin Institute's ARK-Genomics Centre for Comparative and Functional Genomics received a $1.8 million boost from the U.K -More- 

Inform Genomics Presents Results for OnPART(tm) Showing High Degree of Accuracy Predicting Six Common Side Effects of FOLFOX Chemotherapy for Colon Cancer

Boston, MA, Jan. 28, 2013 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a private company focused on developing novel platforms of genomic-based personalized medicine products for cancer supportive care...

Ready or Not, Genomics is Coming to a Hospital Near You

First came genomics for scientists. Then came genomics for Big Pharma. But this year, at a faster pace than many industry insiders anticipated, we’re seeing genomics enter the world of real-life car...

Drugs and Medications [ 6 Associated Drugs and Medications listed on BioPortfolio]

Azathioprine [Roxane Laboratories, Inc]

AZATHIOPRINE Tablets USP, 50 mg

Imuran [Prometheus Laboratories Inc.]

IMURAN (azathioprine)50-mg Scored Tablets

Azasan [Salix Pharmaceuticals, Inc.]

AZASAN (azathioprine)Azathioprine Tablets, USP75 mg Scored Tablets100 mg Scored Tablets

Azathioprine [Zydus Pharmaceuticals (USA) Inc.]

Azathioprine Tablets, USP

Azathioprine [Cadila Healthcare Limited]

Azathioprine Tablets, USP

PubMed Articles [ 237 Associated PubMed Articles listed on BioPortfolio]

Wildlife forensics. Genomics has become a powerful tool to inform conservation measures.

The success of structural genomics.

The International Conference on Structural Genomics (ICSG 2011, http://www.icsg2011.org ), held in Toronto Canada May 10-14, 2011 was a rich and exciting demonstration of how far structural genomics h...

Personal Genomics: are we debating the right Issues?.

The debate about personal genomics and their role in personalized medicine has been, to some extent, hijacked by the controversy about commercially available genomic tests sold directly to consumers....

Functional Genetic Polymorphisms from Phase-II Drug Metabolizing Enzymes.

Genomics in the ecological arena.

This meeting report presents the cutting-edge research that is developing around the waterflea Daphnia, an emerging model system in environmental genomics. Daphnia has been a model species in ecology,...

Clinical Trials [ 127 Associated Clinical Trials listed on BioPortfolio]

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Inflammatory Genomics in Human Carotid Artery Disease

To investigate the relationship between genetic variation in genes for inflammation and carotid artery atherosclerosis.

A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers.

Dopamine (DA) plays a critical role in nicotine (and other) addiction and this drug is known to release DA in brain areas mediating reward and motivational processes. Although imaging stud...

A Functional Magnetic Resonance Imaging (fMRI) Study of Expectancy on Acupuncture Treatment Outcomes in Knee Osteoarthritis (OA)

The results of the proposed experiments will directly inform clinicians who treat patients with osteoarthritis of the knee about how to maximize the benefits of acupuncture treatments. An...

Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology

This research seeks to establish a neonatal DNA Tissue Bank to find out if differences in small segments of DNA predispose babies to Chronic Lung Disease (CLD), Periventricular Brain Injur...

Companies [ 377 Associated Companies listed on BioPortfolio]

Inform Genomics, Inc.

Inform Genomics, Inc. is a private company focused on developing a novel platform of personalized medicine products for cancer supportive care and inflammatory diseases. Our busin...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Center for Genomics and Bioinformatics

Center for Genomics and Bioinformatics The Center for Genomics and Bioinformatics (CGB) was launched in 1997 as a new academic department at the Karolinska Institute. Since then, the department has be...

The Harris SAFE System

HSC is pleased to inform consumers that there is a new tool to aid them in their search for answers about hair replacement surgery. Available now, Dr. James Harris has co-authored a book titled: The H...

More Information about "Inform Genomics, Inc." on BioPortfolio

We have published hundreds of Inform Genomics, Inc. news stories on BioPortfolio along with dozens of Inform Genomics, Inc. Clinical Trials and PubMed Articles about Inform Genomics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inform Genomics, Inc. Companies in our database. You can also find out about relevant Inform Genomics, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement